
Nissa M. Westerberg
Examiner (ID: 14401, Phone: (571)270-3532 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 4173, 1618 |
| Total Applications | 1092 |
| Issued Applications | 237 |
| Pending Applications | 120 |
| Abandoned Applications | 768 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17020959
[patent_doc_number] => 20210244830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/972798
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972798 | TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS | Jun 11, 2019 | Abandoned |
Array
(
[id] => 15205925
[patent_doc_number] => 20190365649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED THIAZOLIDINEDIONES AND LIPOSOME-ENCAPSULATED VASODILATORS, AND THEIR USE TO AMELIORATE ATHEROMA
[patent_app_type] => utility
[patent_app_number] => 16/428681
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428681 | COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED THIAZOLIDINEDIONES AND LIPOSOME-ENCAPSULATED VASODILATORS, AND THEIR USE TO AMELIORATE ATHEROMA | May 30, 2019 | Abandoned |
Array
(
[id] => 17280835
[patent_doc_number] => 11197848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Topical amlodipine salts for the treatment of anorectal diseases
[patent_app_type] => utility
[patent_app_number] => 16/425028
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9081
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/425028 | Topical amlodipine salts for the treatment of anorectal diseases | May 28, 2019 | Issued |
Array
(
[id] => 16990305
[patent_doc_number] => 20210228725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/051507
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051507 | DRUG DELIVERY | Apr 29, 2019 | Abandoned |
Array
(
[id] => 14743827
[patent_doc_number] => 20190255087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => ENCAPSULATION AND HIGH LOADING EFFICIENCY OF PHOSPHORYLATED DRUG AND IMAGING AGENTS IN NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/383193
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383193 | ENCAPSULATION AND HIGH LOADING EFFICIENCY OF PHOSPHORYLATED DRUG AND IMAGING AGENTS IN NANOPARTICLES | Apr 11, 2019 | Abandoned |
Array
(
[id] => 16806183
[patent_doc_number] => 20210128736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY
[patent_app_type] => utility
[patent_app_number] => 17/044189
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044189 | STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY | Mar 31, 2019 | Abandoned |
Array
(
[id] => 16761120
[patent_doc_number] => 20210106701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PSMA-TARGETED RADIOPHARMACEUTICAL FOR DIAGNOSING AND TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/981432
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981432 | PSMA-targeted radiopharmaceutical for diagnosing and treating prostate cancer | Mar 28, 2019 | Issued |
Array
(
[id] => 14926203
[patent_doc_number] => 20190298739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => TREATMENT OF CALCIFIC AORTIC VALVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/367964
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367964
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/367964 | TREATMENT OF CALCIFIC AORTIC VALVE DISEASE | Mar 27, 2019 | Abandoned |
Array
(
[id] => 15862595
[patent_doc_number] => 20200138701
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-05-07
[patent_title] => Punctal Plug With Active Agent
[patent_app_type] => utility
[patent_app_number] => 16/360561
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360561 | Punctal Plug With Active Agent | Mar 20, 2019 | Abandoned |
Array
(
[id] => 15862595
[patent_doc_number] => 20200138701
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-05-07
[patent_title] => Punctal Plug With Active Agent
[patent_app_type] => utility
[patent_app_number] => 16/360561
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360561
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360561 | Punctal Plug With Active Agent | Mar 20, 2019 | Abandoned |
Array
(
[id] => 14563711
[patent_doc_number] => 20190209462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Octreotide depot formulation with constantly high exposure levels
[patent_app_type] => utility
[patent_app_number] => 16/352986
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16352986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/352986 | Octreotide depot formulation with constantly high exposure levels | Mar 13, 2019 | Abandoned |
Array
(
[id] => 16727775
[patent_doc_number] => 20210094922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Dyes for Analysis of Soluble Protein Aggregates or Misfolded Protein Oligomers
[patent_app_type] => utility
[patent_app_number] => 16/978479
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978479
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978479 | Dyes for Analysis of Soluble Protein Aggregates or Misfolded Protein Oligomers | Mar 6, 2019 | Abandoned |
Array
(
[id] => 16554992
[patent_doc_number] => 20210000140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => METHOD FOR OBTAINING PROTEINS OR A RICH-PROTEIN EXTRACT FROM ALGAE, EXTRACTS AND USES THEREFORE
[patent_app_type] => utility
[patent_app_number] => 16/979059
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979059 | METHOD FOR OBTAINING PROTEINS OR A RICH-PROTEIN EXTRACT FROM ALGAE, EXTRACTS AND USES THEREFORE | Mar 5, 2019 | Abandoned |
Array
(
[id] => 14774203
[patent_doc_number] => 20190261999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => DEVICES FOR DELIVERY OF TREATMENT AGENTS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/284168
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284168 | DEVICES FOR DELIVERY OF TREATMENT AGENTS AND RELATED METHODS | Feb 24, 2019 | Abandoned |
Array
(
[id] => 16523686
[patent_doc_number] => 20200397766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => POROUS EMBOLIZATION MICROSPHERES COMPRISING DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/970975
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970975 | POROUS EMBOLIZATION MICROSPHERES COMPRISING DRUGS | Feb 21, 2019 | Abandoned |
Array
(
[id] => 14433761
[patent_doc_number] => 20190174752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => SYNTHETIC POLYMER FILM HAVING SURFACE PROVIDED WITH BACTERICIDAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/275072
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/275072 | SYNTHETIC POLYMER FILM HAVING SURFACE PROVIDED WITH BACTERICIDAL ACTIVITY | Feb 12, 2019 | Abandoned |
Array
(
[id] => 17080681
[patent_doc_number] => 20210275687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => NANOSYSTEMS AS SELECTIVE VEHICLES
[patent_app_type] => utility
[patent_app_number] => 16/962196
[patent_app_country] => US
[patent_app_date] => 2019-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962196 | NANOSYSTEMS AS SELECTIVE VEHICLES | Jan 14, 2019 | Abandoned |
Array
(
[id] => 17503274
[patent_doc_number] => 20220096376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => DRUG DELIVERY PLATFORM USING W/O/W-TYPE TRIOLEIN EMULSION PROMOTIVE OF BLOOD-BRAIN BARRIER OPENING
[patent_app_type] => utility
[patent_app_number] => 17/421005
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421005
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421005 | DRUG DELIVERY PLATFORM USING W/O/W-TYPE TRIOLEIN EMULSION PROMOTIVE OF BLOOD-BRAIN BARRIER OPENING | Jan 6, 2019 | Abandoned |
Array
(
[id] => 15290857
[patent_doc_number] => 20190388564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Synthetic Scaffolds for Metastasis Detection
[patent_app_type] => utility
[patent_app_number] => 16/241440
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241440 | Synthetic Scaffolds for Metastasis Detection | Jan 6, 2019 | Abandoned |
Array
(
[id] => 16397277
[patent_doc_number] => 20200338135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE PRODUCTION PROMOTING AGENT
[patent_app_type] => utility
[patent_app_number] => 16/958962
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958962 | LIPOCALIN-TYPE PROSTAGLANDIN D2 SYNTHASE PRODUCTION PROMOTING AGENT | Dec 26, 2018 | Abandoned |